Reduced levels of convalescent neutralizing antibodies against SARS-CoV-2 B.1+L249S+E484K lineage-Reference-Cited by-同舟云学术

Reduced levels of convalescent neutralizing antibodies against SARS-CoV-2 B.1+L249S+E484K lineage

Published:2022-01 Issue: Volume:308 Page:198629
ISSN:0168-1702
Container-title:Virus Research
language:en
Short-container-title:Virus Research

Author:

Álvarez-Díaz Diego A.,Laiton-Donato Katherine,Torres-García Orlando Alfredo,Ruiz-Moreno Hector Alejandro,Franco-Muñoz Carlos,Beltran Maria Angie,Mercado-Reyes Marcela,Rueda Miguel Germán,Muñoz Ana Luisa

Publisher

Elsevier BV

Subject

Cancer Research,Infectious Diseases,Virology

Reference33 articles.

1. Evaluation of MERS-CoV neutralizing antibodies in sera using live virus microneutralization assay;Algaissi;Methods Mol. Biol.,2020

2. Evaluation of neutralizing antibodies against highly pathogenic coronaviruses: a detailed protocol for a rapid evaluation of neutralizing antibodies using vesicular stomatitis virus pseudovirus-based assay;Almahboub;Front. Microbiol.,2020

3. Emergence and expansion of SARS-CoV-2 B.1.526 after identification in New York;Annavajhala;Nature,2021

4. Tracking changes in SARS-CoV-2 Spike: evidence that D614G increases infectivity of the COVID-19 virus;Korber;Cell,2020

5. Novel SARS-CoV-2 variants: the pandemics within the pandemic;Boehm;Clin. Microbiol. Infect.,2021

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Wastewater sequencing as a powerful tool to reveal SARS-CoV-2 variant introduction and spread in French Guiana, South America;Science of The Total Environment;2024-05

2. SARS-CoV-2 infection in newborn infants: descriptive epidemiological analysis of cases reported to the Colombian national surveillance system during the first pandemic year, March 2020–February 2021;BMJ Paediatrics Open;2023-03

3. Neutralizing Antibody Responses Elicited by Inactivated Whole Virus and Genetic Vaccines against Dominant SARS-CoV-2 Variants during the Four Epidemic Peaks of COVID-19 in Colombia;Vaccines;2022-12-14

4. Clinical outcomes associated with Mu variant infection during the third epidemic peak of COVID-19 in Colombia;International Journal of Infectious Diseases;2022-12

5. Neutralizing responses in fully vaccinated with BNT162b2, CoronaVac, ChAdOx1, and Ad26.COV2.S against SARS-CoV-2 lineages in Colombia, 2020-2021;2022-03-15